Regulatory information firm swallowed by Instem
DEESIDE regulatory information management specialist Samarind has been acquired by Instem, a provider of IT services to the global early development healthcare market.
Law firms Squire Patton Boggs and Hill Dickinson have advised on the deal, the value of which has not been disclosed.
Samarind provides a service to the life sciences sector which significantly improves the quality of regulatory information and helps achieve and maintain compliance for pharmaceutical, biotech and medical device products.
“On behalf of our clients and staff, we couldn’t be happier to be part of the Instem group and the transformation they are leading in health and life sciences,” said Dr Olaf Schoepke, vice president, regulatory solution development at Samarind.
“This acquisition by Instem brings core clinical and regulatory capabilities together so we can expand the value and impact that we bring to our client partners.”
Mike Harwood, Instem’s executive vice president of regulatory solutions said: “Samarind aligns perfectly with our strategy of harmonizing IT systems and processes in today’s competitive marketplace.
“Through our organic and acquisitive growth, we are answering the call of our clients to create a highly functional ecosystem to help them bring life enhancing products to market faster.”
Squire Patton Boggs advised Stone, Stafford-based Instem , led by Giles Chesher with support from Laura Green. The sellers were advised by a team from Hill Dickinson led by Ian Riggs and including James Down with corporate finance adviser Greg Barker of Strategic Corporate Finance also advising the sellers.
